Analysis

Thiogenesis Therapeutics Corp (TTI) Stock Analysis

Thiogenesis Therapeutics Corp investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to TTI.

websiteTTI/analysis/TTI

Thiogenesis Therapeutics Corp

Thiogenesis Therapeutics Corp investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to TTI.

Stock profile

Ticker

TTI

Asset type

Stock

Market cap

$28.7M

Sector

Finance

Industry

Financial Conglomerates

Currency

CAD

Ticker listings

Thiogenesis Therapeutics Corp may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • TTI primary listing
  • Q8M
  • TTIPF

Latest Thiogenesis Therapeutics Corp news

Thiogenesis Appoints Dr. Gilad Aharon to Its Board of Directors

San Diego, California--(Newsfile Corp. - June 17, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechno...

Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million

San Diego, California--(Newsfile Corp. - June 3, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company deve...

Thiogenesis Upsizes Non-Brokered Private Placement of Common Shares

San Diego, California--(Newsfile Corp. - June 1, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnolo...

Thiogenesis Announces Non-Brokered Private Placement

San Diego, California--(Newsfile Corp. - May 11, 2026) - Thiogenesis Therapeutics Corp. (TSXV: T...

Thiogenesis Therapeutics to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

San Diego, California--(Newsfile Corp. - April 16, 2026) - Thiogenesis Therapeutics, Corp. (TSXV...

Research sections

Valuation

Review valuation context for Thiogenesis Therapeutics Corp.

Future growth

Review future growth context for Thiogenesis Therapeutics Corp.

Past performance

Review past performance context for Thiogenesis Therapeutics Corp.

Financial health

Review financial health context for Thiogenesis Therapeutics Corp.

Dividend

Review dividend context for Thiogenesis Therapeutics Corp.

Management

Review management context for Thiogenesis Therapeutics Corp.

Ownership

Review ownership context for Thiogenesis Therapeutics Corp.

Other information

Review other information context for Thiogenesis Therapeutics Corp.

Community

Review community context for Thiogenesis Therapeutics Corp.